GT Biopharma Inc. Common Stock
Symbol: GTBP (NASDAQ)
0.68
▲ (0.15%) 0.001
Company Description:
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
Key Stats
- Today's Open: $0.678
- Today's High: $0.704
- Today's Low: $0.671
- Today's Volume: 360.38K
- Yesterday Close: $0.682
- Yesterday High: $0.7335
- Yesterday Low: $0.6731
- Yesterday Volume: 699.04K
- Last Min Volume: 119
- Last Min High: $0.683
- Last Min Low: $0.683
- Last Min VWAP: $0.683
Company Profile
- Name: GT Biopharma Inc. Common Stock
- Website: https://www.gtbiopharma.com
- Listed Date: 2021-02-11
- Location: SAN FRANCISCO, CA
- Market Status: Active
- CIK Number: 0000109657
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $2.46M
- Round Lot: 100
- Outstanding Shares: 3.56M
- Asset Type: CS
RECENT FILINGS FOR GTBP
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-26 | 8-K | View |
| 2025-09-23 | 8-K | View |
| 2025-09-08 | 4 | View |
| 2025-09-08 | 4 | View |
| 2025-09-08 | 4 | View |
| 2025-09-08 | 4 | View |
| 2025-09-08 | 4 | View |
| 2025-08-29 | 8-K | View |
| 2025-08-14 | 10-Q | View |
| 2025-07-30 | 3 | View |
| 2025-07-24 | 8-K | View |
| 2025-07-03 | 424B3 | View |
| 2025-07-02 | EFFECT | View |
| 2025-07-01 | CORRESP | View |
| 2025-06-27 | S-1/A | View |
| 2025-06-27 | CORRESP | View |
| 2025-06-20 | UPLOAD | View |
| 2025-06-11 | S-1 | View |
| 2025-06-11 | DEFA14A | View |
| 2025-06-11 | DEF 14A | View |
Latest News on GTBP